tradingkey.logo
tradingkey.logo
Buscar

Check Cap Ltd

CHEK
Añadir a la lista de seguimiento
1.610USD
0.0000.00%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
8.00MCap. mercado
PérdidaP/E TTM

Más Datos de Check Cap Ltd Compañía

Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.

Información de Check Cap Ltd

Símbolo de cotizaciónCHEK
Nombre de la empresaCheck Cap Ltd
Fecha de salida a bolsaFeb 19, 2015
Director ejecutivoOvadia (Alex)
Número de empleados- -
Tipo de seguridadOrdinary Share
Fin del año fiscalFeb 19
Dirección29 Abba Hushi Ave.
Ciudad
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísIsrael
Código postal3009000
Teléfono97248303401
Sitio Webhttps://check-cap.com/
Símbolo de cotizaciónCHEK
Fecha de salida a bolsaFeb 19, 2015
Director ejecutivoOvadia (Alex)

Ejecutivos de Check Cap Ltd

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
--
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
--
--
Mr. Joshua (Shuki) Belkar
Mr. Joshua (Shuki) Belkar
Vice President - Operations
Vice President - Operations
--
--
Mr. Israel Hershko
Mr. Israel Hershko
Vice President - Quality Assurance and Regulatory Affairs
Vice President - Quality Assurance and Regulatory Affairs
--
--
Ms. Irina Koffler
Ms. Irina Koffler
Investor Relations
Investor Relations
--
--
Dr. Hanit Brenner-lavie
Dr. Hanit Brenner-lavie
Vice President - Clinical Affairs
Vice President - Clinical Affairs
--
--
Mr. Dan Hilerowitz
Mr. Dan Hilerowitz
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Yoav Kimchy, Ph.D.
Dr. Yoav Kimchy, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Alex Ovadia
Mr. Alex Ovadia
Chief Executive Officer
Chief Executive Officer
--
--
Mr. Steven J. Hanley
Mr. Steven J. Hanley
Chairman of the Board
Chairman of the Board
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Boaz Shpigelman
Mr. Boaz Shpigelman
Vice President - Research and Development
Vice President - Research and Development
--
--
Ms. Clara Ezed
Ms. Clara Ezed
Independent Director
Independent Director
--
--
Mr. Joshua (Shuki) Belkar
Mr. Joshua (Shuki) Belkar
Vice President - Operations
Vice President - Operations
--
--
Mr. Israel Hershko
Mr. Israel Hershko
Vice President - Quality Assurance and Regulatory Affairs
Vice President - Quality Assurance and Regulatory Affairs
--
--
Ms. Irina Koffler
Ms. Irina Koffler
Investor Relations
Investor Relations
--
--
Dr. Hanit Brenner-lavie
Dr. Hanit Brenner-lavie
Vice President - Clinical Affairs
Vice President - Clinical Affairs
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Check Cap Ltd?

Los cinco principales accionistas de Check Cap Ltd son: Mr. Boaz Shpigelman

¿Cuántas instituciones poseen acciones de Check Cap Ltd (CHEK)?

A fecha de 2026Q1, 30 instituciones poseen acciones de Check Cap Ltd, con un valor de mercado combinado de aproximadamente 47.75K, lo que representa el 0.68% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -132985.00.